A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
Crossref DOI link: https://doi.org/10.1186/s12906-015-0861-7
Published Online: 2015-09-23
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Luangchosiri, Chote
Thakkinstian, Ammarin
Chitphuk, Sermsiri
Stitchantrakul, Wasana
Petraksa, Supanna
Sobhonslidsuk, Abhasnee
License valid from 2015-09-23